Jaguar Animal Health (JAGX) Stock Statistics & Valuation Metrics

Jaguar Animal Health has a market cap or net worth of $3.65M. The enterprise value is $43.20M.

Jaguar Animal Health has 13,019,277 shares outstanding. The number of shares has decreased by -2.65% in one year.

Jaguar Animal Health’s return on equity (ROE) is 3.10 and return on invested capital (ROIC) is -180.03%.

The current PE Ratio of Jaguar Animal Health is ―. Jaguar Animal Health’s PEG ratio is 0.00049.

In the last 12 months, Jaguar Animal Health had revenue of 11.51M and earned -53.58M in profits. Earnings per share was -22.97.

In the last 12 months, operating cash flow was -23.74M and capital expenditures -25.00K, giving a free cash flow of -23.77M billion.

Jaguar Animal Health pays an annual dividend of ―, resulting in a dividend yield of ―

Jaguar Animal Health upcoming earnings date is May 18, 2026, TBA (Confirmed).

Jaguar Animal Health as a current ratio of 0.50, with Debt / Equity ratio of -252.22%

In the past 12 months, Jaguar Animal Health has paid -422.00K in taxes.

Jaguar Animal Health EV to EBITDA ratio is -0.98, with an EV/FCF ratio of 7.76.

Jaguar Animal Health has $968.00K in cash and marketable securities with $43.61M in debt, giving a net cash position of -$42.64M billion.

Gross margin is 67.21%, with operating margin of -398.82%, and net profit margin of -465.42%.

The average price target for Jaguar Animal Health is ―, which is 11.43% higher than the current price. The consensus rating is ―